טוען...
Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differe...
שמור ב:
| הוצא לאור ב: | Infect Chemother |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5204005/ https://ncbi.nlm.nih.gov/pubmed/28032484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2016.48.4.267 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|